A p-iodophenol-enhanced luminescent end-point has been incorporated into a commercially available heterogeneous competitive enzyme immunoassay for digoxin based on a horseradish peroxidase-digoxin conjugate. The luminescent end-point could be completed in less than 1 min and significantly reduced overall assay time. Results for the assay obtained using enhanced luminescence showed good agreement with those obtained using a colorimetric end-point (correlation coefficient 0·98). Both assays gave acceptable precision within the therapeutic range. The incubation time for the luminescent immunoassay was reduced to 15 min and still gave differentiation between sub-therapeutic, therapeutic and toxic levels of digoxin.
A p-iodophenol-enhanced luminescent end-point has been incorporated into a commercially available heterogeneous competitive enzyme immunoassay for digoxin based on a horseradish peroxidase-digoxin conjugate. The luminescent end-point could be completed in less than 1 min and significantly reduced overall assay time. Results for the assay obtained using enhanced luminescence showed good agreement with those obtained using a colorimetric end-point (correlation coefficient 0·98). Both assays gave acceptable precision within the therapeutic range. The incubation time for the luminescent immunoassay was reduced to 15 min and still gave differentiation between sub-therapeutic, therapeutic and toxic levels of digoxin.
Digoxin is the cardiac glycoside most widely used in the treatment of heart failure and certain disturbances of cardiac rhythm. 1 However, the therapeutic range of digoxin is narrow and the toxic effects of the drug manifest themselves at only slightly higher serum levels. 2 The therapeutic range of serum digoxin (including digoxin derivatives) is 0·5-2·0 ng/rnl.r' Digoxin overdosage results in nausea, vomiting, delirium, decreased blood pressure and death, usually from ventricular fibrillation. Successful treatment depends on prompt recognition and the withdrawal of therapy." If a patient starts to develop adverse symptoms when receiving the drug, rapid measurement of serum levels can help in the confirmation of digoxin toxicity.
There are many methods for measuring serum digoxin levels, including radioimmunoassay,5 fluoroimmunoassay, 1 Ltd, Lewes, East Sussex, UK) and this has been evaluated and compared with a radioimmunoassay. H This assay employs a colorimetric end-point (ABTS-peroxide) which takes 60 min to complete. The recently discovered enhanced luminescence phenomenon in which HRPcatalysed light emission from cyclic diacyl hydrazides such as luminol is dramatically increased by addition of6-hydroxybenzothiazole derivatives" or substituted phenols, III provides an alternative end-point which is both rapid (seconds) and sensitive. [11] [12] [13] [14] We describe here the application of enhanced luminescence in an enzyme immunoassay for serum digoxin and its exploitation in reducing overall assay time.
Materials and methods
p-Iodophenol was supplied by Aldrich Chemical Company (Gillingham, Dorset, UK). Luminol, hydrogen peroxide (30% w/v) and dimethyl sulphoxide were purchased from Sigma Chemical Company (Poole, Dorset, UK). Luminol was converted to its sodium salt and purified by recrystallisation from sodium hydroxide and decolourisation with charcoal. Peroxidase luminescent substrate was prepared by addition of 1·1 mL p-iodophenol (34,1 mrnol/L in dimethyl sulphoxide) to 100 mL obtained by analysing replicate samples from serum specimens within a single assay.
Results
Standard curves of digoxin assayed using enzyme immunoassays with a colorimetric and a p-iodophenol-enhanced luminescence endpoint are shown in Fig. 1 . Expressing the values obtained from both assays as a percentage of the maximum response revealed that the luminescent method produced a slightly steeper calibration curve.
In the p-iodophenol-enhanced luminescent assay, light is emitted as a high intensity glow rather than as a rapid flash and is relatively stable for several minutes (Fig. 2 ). Light intensity was measured after 30 s, but acceptable standard curves can also be obtained from sets of measurements made at other times after the initiation of the reaction. The total time needed to quantitate the bound peroxidase label was less than 1 min compared to 1 h for the colorimetric assay. of a luminol (3·1 mmolJL), hydrogen peroxide (7,3 mmol/L) mixture prepared in Tris buffer (0·1 molJL, pH 8, 5) . This solution was stored protected from light prior to use. SPECIMENS A total of 34 serum specimens supplied by the Toxicology Department, Dudley Road Hospital, Birmingham, UK, were studied. These were assayed using (i) a commercial ELISA kit with a colorimetric end-point and (ii) the same ELISA kit but with an enhanced luminescence end-point.
IMMUNOASSAY PROCEDURE
An Enzymun-Test Digoxin ELISA kit (Lot: 1472334, BeL Ltd, Lewes, East Sussex, UK) was used to assay standards and specimens in duplicate following the manufacturers' instructions. Plastic tubes coated with anti-digoxin antibodies raised in sheep were incubated with 100 ul, of serum standard or specimen and 1·0 mL of peroxidase-labelled digoxin conjugate for 1 h at room temperature. The contents were then aspirated, the tubes washed twice with cold tap water and bound conjugate quantitated.
COLORIMETRIC END-POINT
Tubes were incubated at room temperature for 1 h with 1·0 mL phosphate-citrate buffer (0,1 molJL, pH 5,0) containing 2,2'-azinodi-(3-ethylbenzothiazoline-6-sulphonate) (9·1 mmolJL) and sodium perborate (1·47 mmol/L). Tubes were then mixed, the liquid transferred to microcuvettes and the absorbance measured at 420 nm using a Shimadzu UV 240 spectrophotometer.
ENHANCED LUMINESCENT END-POINT
Immediately. after the final wash procedure 0·6 mL Tris buffer (0,1 mollL, pH 8,5) was added to each tube. Individual luminescent reactions were then initiated manually by the addition of 0·4 mL of the luminol (3,07 mmolJL}--hydrogen peroxide (7,2 mmolJL}-p-iodophenol (0,37 mmolJL) substrate mixture.
The contents of the tubes were mixed, tubes placed in a luminometer '? and the light intensity after 30 s recorded as photo-current from a side-window photomultiplier tube (EMI type 9781A, 94 f.lNLumen). can lose activity. Although this effect can be prevented by covering the active surface of the tube with distilled water or buffer, bound conjugate can become detached from the walls and lost if storage buffer is removed. For example, a 20% and a 70% loss of bound HRP conjugate occurred from tubes stored for 15 min filled with distilled water or with phosphate buffered saline (pH 7·3) containing 0·1 % Tween 20, respectively. In the enhanced luminescent enzyme immunoassay loss of conjugate was avoided as tubes were stored containing Tris assay buffer to which luminescent substrate solution was directly added prior to light measurement. The incubation time with sample and conjugate was successively reduced to discover how short an incubation time could be used without losing differentiation between stan- For a series of 34 serum specimens good correlation (r=0'98, regression line y=0'96x +0,07) was obtained between results from the colorimetric and enhanced luminescent immunoassays (Fig. 3 ). Both assays gave acceptable precision for digoxin concentrations in the therapeutic range (Table 1) .
Sequential analysis of large batches of samples may involve storage of assay tubes prior to quantitation of the bound label. If the tube surface dries out during storage, bound label dards. Reduction of the time to 45 min produced minimal change. Incubations of 30 and 15 min resulted in decreased light emission but differentiation between digoxin concentrations in the sub-therapeutic, therapeutic and toxic regions was still possible (Fig. 4 ). Reducing the time to 5 min produced no differentiation.
Discussion
This luminescently monitored immunoassay demonstrates that the colorimetric end-point of a conventional enzyme immunoassay for digoxin can be advantageously replaced with a piodophenol-enhanced luminescent end-point. This has a dramatic effect on the time taken to perform an assay, reducing it from 2 h to just over 1 h. Good sensitivity and acceptable precision were achieved despite the use of tubes that were not specifically designed for luminescent measurements and the fact that only 50% of their active surface was visible to the photodetector. The use of tubes fully compat-
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ible with luminometers should improve precision, sensitivity, and the ease with which bound conjugate is quantitated. Chemiluminescent reactions of cyclic diacyl hydrazides have been used to detect drug? or steroid-HRP conjugates'v " in enzyme irnmunoassays. However, enhanced luminescent reactions produce a more intense light emission which is readily and rapidly detected even using simple instrumentation.t? As light emission continues for many minutes there is no requirement for high speed initiation of individual reactions directly in front of the photodetector and rapid measurement of light intensity can be made several minutes after initiation. Effects due to changes in the kinetics of light emission are minimised by taking measurements at fixed times after initiation.
Good correlation was achieved with results obtained colorimetrically in this preliminary study. However, further studies are required to re-assess the influence of haemolysed, icteric or turbid samples" in competitive immunoassays with an enhanced chemiluminescent end-point. Although no attempt was made to improve the kinetics of the immunological reaction, the feasibility of reducing the incubation time to 15 min was demonstrated, thus making it comparable to fluorescence polarisation immuno-assay20 in terms of total assay time.
The p-iodophenol-enhanced luminescent assay has general applicability to immunoassays employing HRP conjugates and can be used in conjunction with a variety of solid supports such as beads, tubes or microtitre plates. Reactions can be monitored using simple instrumentation and the speed and sensitivity of the technique should produce useful reductions in the overall assay time of enzyme immunoassays for many clinically useful analytes.
